Mastering data integrity and Good Documentation Practice is essential for maintaining regulatory compliance and ensuring scientific validity in therapeutic goods development and manufacturing. These principles form the backbone of trustworthy data systems and are essential for demonstrating control, traceability, and reproducibility.
Showing maturity without overselling is a strategic imperative for organisations operating under GxP and regulatory compliance frameworks. Evidence-based demonstration, transparent communication, incremental progress, alignment with regulatory standards, and a culture of continuous improvement collectively convey maturity credibly.
This case study demonstrates the critical importance of GMP support for wholesalers of radiopharmaceuticals. By partnering with Quality Systems Now, the client was able to implement comprehensive quality systems, enhance staff competency, and ensure compliance with regulatory requirements.
AusBiotech 2025 offered a valuable reflection point for the biotechnology sector, particularly regarding GMP and regulatory compliance.